A new study questions the use of stents in certain patients; the House is expected to pass CHIP funding, but how to pay for it continues to be debated; and nearly all older, poorer people will have access to cheaper ACA plans in 2018.
Stents may not provide as much benefit for heart patients as originally thought. According to The Wall Street Journal, researchers found stents didn’t provide patients with angina with a significant improvement in exercise time on a treadmill. These patients are only a small number of the total population of patients who currently receive stents, but the findings could have a big impact on the business of stent manufacturers. The study’s findings do not apply to patients having heart attacks; past studies have shown stents can save lives in these patients.
Although there is still debate on how to pay for funding for the Children’s Health Insurance Program (CHIP), the House is expected to pass legislation to refinance CHIP. The bill would ensure funding for the program, but it is expected to pass mostly along party lines, with a tougher road to pass in the Senate, according to The New York Times. Both parties have agreed to fund CHIP for 5 years and community health centers for 2 years, but are split on how to pay for the funding. Republicans want to use money in an Affordable Care Act (ACA) fund for public health efforts, which Democrats are strongly opposed to.
The Trump administration’s decision to end funding for cost-sharing reduction payments is having an unintended consequence: more people will have cheaper or free options in 2018. The Washington Post reported that the move has led to increased federal subsidies and that older people with low incomes will benefit the most. In 98% of counties, this population would be able to get a bronze plan with no premium. It is unclear yet if this new quirk to the ACA will offset expected enrollment losses.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More